Results
Differentially Expressed miRNAs List
miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
---|---|---|---|---|---|---|---|---|
hsa-miR-367 | GSE5244 | uterus cancer | uterus cancer | N/A | cancer vs normal | -0.61 | DOWN | EXP00030 |
hsa-miR-367 | GSE6188 | esophageal cancer | esophageal cancer | N/A | cancer vs normal | 0.34 | UP | EXP00031 |
hsa-miR-367 | GSE6636 | prostate cancer | prostate cancer | N/A | cancer vs normal | 5.50 | UP | EXP00032 |
hsa-miR-367 | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.71 | UP | EXP00042 |
hsa-miR-367 | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.87 | UP | EXP00043 |
hsa-miR-367 | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.69 | UP | EXP00044 |
hsa-miR-367 | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.68 | UP | EXP00045 |
hsa-miR-367 | GSE8126 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.78 | UP | EXP00046 |
hsa-miR-367 | GSE7055 | prostate cancer | prostate cancer | N/A | poor outcome vs good outcome | 0.35 | UP | EXP00082 |
hsa-miR-367 | GSE16558 | lymphoma | lymphoma | N/A | cancer vs normal | -0.48 | DOWN | EXP00076 |
hsa-miR-367 | GSE6857 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.50 | UP | EXP00081 |
hsa-miR-367 | GSE15008 | lung cancer | lung cancer | N/A | cancer vs normal | 0.49 | UP | EXP00070 |
hsa-miR-367 | GSE2399 | lymphoma | lymphoma | Namalwa | subtype1 vs substype2 | -2.00 | DOWN | EXP00016 |
hsa-miR-367 | GSE4589 | breast cancer | breast cancer | N/A | cancer vs normal | 2.36 | UP | EXP00029 |
hsa-miR-367 | GSE16025 | lung cancer | lung cancer | N/A | cancer vs normal | -0.21 | DOWN | EXP00071 |